Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 526 | 988 | 577 | 1,244 | 3,459 |
| Gross Profit | 526 | 988 | 577 | 1,244 | 3,459 |
| Operating Expenses | 75,172 | 58,047 | 48,218 | 44,002 | 33,131 |
| Operating Income | -74,646 | -57,059 | -47,641 | -42,758 | -29,672 |
| Other Income | 2,270 | 2,786 | 1,946 | 1,846 | 1,400 |
| Pre-tax Income | -72,376 | -54,273 | -45,695 | -40,912 | -28,272 |
| Net Income Continuous | -72,376 | -54,273 | -45,695 | -40,912 | -28,272 |
| Net Income | $-72,376 | $-54,273 | $-45,695 | $-40,912 | $-28,272 |
| EPS Basic Total Ops | -1.88 | -1.38 | -1.26 | -1.17 | -0.89 |
| EPS Basic Continuous Ops | -1.87 | -1.38 | -1.26 | -1.17 | -0.89 |
| EPS Diluted Total Ops | -1.88 | -1.38 | -1.26 | -1.17 | -0.89 |
| EPS Diluted Continuous Ops | -1.87 | -1.38 | -1.26 | -1.17 | -0.89 |
| EBITDA(a) | $-75,156 | $-57,856 | $-48,633 | $-43,631 | $-30,191 |